Selected research
Industry Growth & Trends
Global Filgrastim Industry Growth and Trends Forecast to 2032
Market perspective
The global Filgrastim market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Filgrastim include SANDOZ INC, Amgen and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Filgrastim market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Filgrastim market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Filgrastim market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Filgrastim.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Filgrastim market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Filgrastim Market by Company
SANDOZ INC
Amgen
Teva
Filgrastim Segment by Type
Lyophilized Powder
Others
Filgrastim Segment by Application
Solid Tumor
Kidney Cancer
Lymphoma
Lung Disease
Others
Filgrastim Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Filgrastim and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Filgrastim in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lyophilized Powder
- Others
Applications
- Solid Tumor
- Kidney Cancer
- Lymphoma
- Lung Disease
- Others
Companies covered
- SANDOZ INC
- Amgen
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Filgrastim Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Filgrastim Sales Estimates and Forecasts (2021-2032)
- 1.3 Filgrastim Market by Type
- 1.3.1 Lyophilized Powder
- 1.3.2 Others
- 1.4 Global Filgrastim Market Size by Type
- 1.4.1 Global Filgrastim Market Size Overview by Type (2021-2032)
- 1.4.2 Global Filgrastim Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Filgrastim Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Filgrastim Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Filgrastim Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Filgrastim Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Filgrastim Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Filgrastim Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Filgrastim Industry Trends
- 2.2 Filgrastim Industry Drivers
- 2.3 Filgrastim Industry Opportunities and Challenges
- 2.4 Filgrastim Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Filgrastim Revenue (2021-2026)
- 3.2 Global Top Players by Filgrastim Sales (2021-2026)
- 3.3 Global Top Players by Filgrastim Price (2021-2026)
- 3.4 Global Filgrastim Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Filgrastim Major Company Production Sites & Headquarters
- 3.6 Global Filgrastim Company, Product Type & Application
- 3.7 Global Filgrastim Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Filgrastim Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Filgrastim Players Market Share by Revenue in 2025
- 3.8.3 2025 Filgrastim Tier 1, Tier 2, and Tier 3
4 Filgrastim Regional Status and Outlook
- 4.1 Global Filgrastim Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Filgrastim Historic Market Size by Region
- 4.2.1 Global Filgrastim Sales in Volume by Region (2021-2026)
- 4.2.2 Global Filgrastim Sales in Value by Region (2021-2026)
- 4.2.3 Global Filgrastim Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Filgrastim Forecasted Market Size by Region
- 4.3.1 Global Filgrastim Sales in Volume by Region (2027-2032)
- 4.3.2 Global Filgrastim Sales in Value by Region (2027-2032)
- 4.3.3 Global Filgrastim Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Filgrastim by Application
- 5.1 Filgrastim Market by Application
- 5.1.1 Solid Tumor
- 5.1.2 Kidney Cancer
- 5.1.3 Lymphoma
- 5.1.4 Lung Disease
- 5.1.5 Others
- 5.2 Global Filgrastim Market Size by Application
- 5.2.1 Global Filgrastim Market Size Overview by Application (2021-2032)
- 5.2.2 Global Filgrastim Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Filgrastim Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Filgrastim Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Filgrastim Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Filgrastim Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Filgrastim Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Filgrastim Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 SANDOZ INC
- 6.1.1 SANDOZ INC Company Information
- 6.1.2 SANDOZ INC Business Overview
- 6.1.3 SANDOZ INC Filgrastim Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 SANDOZ INC Filgrastim Product Portfolio
- 6.1.5 SANDOZ INC Recent Developments
- 6.2 Amgen
- 6.2.1 Amgen Company Information
- 6.2.2 Amgen Business Overview
- 6.2.3 Amgen Filgrastim Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Amgen Filgrastim Product Portfolio
- 6.2.5 Amgen Recent Developments
- 6.3 Teva
- 6.3.1 Teva Company Information
- 6.3.2 Teva Business Overview
- 6.3.3 Teva Filgrastim Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Teva Filgrastim Product Portfolio
- 6.3.5 Teva Recent Developments
7 North America by Country
- 7.1 North America Filgrastim Sales by Country
- 7.1.1 North America Filgrastim Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Filgrastim Sales by Country (2021-2026)
- 7.1.3 North America Filgrastim Sales Forecast by Country (2027-2032)
- 7.2 North America Filgrastim Market Size by Country
- 7.2.1 North America Filgrastim Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Filgrastim Market Size by Country (2021-2026)
- 7.2.3 North America Filgrastim Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Filgrastim Sales by Country
- 8.1.1 Europe Filgrastim Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Filgrastim Sales by Country (2021-2026)
- 8.1.3 Europe Filgrastim Sales Forecast by Country (2027-2032)
- 8.2 Europe Filgrastim Market Size by Country
- 8.2.1 Europe Filgrastim Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Filgrastim Market Size by Country (2021-2026)
- 8.2.3 Europe Filgrastim Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Filgrastim Sales by Country
- 9.1.1 Asia-Pacific Filgrastim Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Filgrastim Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Filgrastim Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Filgrastim Market Size by Country
- 9.2.1 Asia-Pacific Filgrastim Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Filgrastim Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Filgrastim Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Filgrastim Sales by Country
- 10.1.1 South America Filgrastim Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Filgrastim Sales by Country (2021-2026)
- 10.1.3 South America Filgrastim Sales Forecast by Country (2027-2032)
- 10.2 South America Filgrastim Market Size by Country
- 10.2.1 South America Filgrastim Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Filgrastim Market Size by Country (2021-2026)
- 10.2.3 South America Filgrastim Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Filgrastim Sales by Country
- 11.1.1 Middle East and Africa Filgrastim Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Filgrastim Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Filgrastim Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Filgrastim Market Size by Country
- 11.2.1 Middle East and Africa Filgrastim Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Filgrastim Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Filgrastim Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Filgrastim Value Chain Analysis
- 12.1.1 Filgrastim Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Filgrastim Production Mode & Process
- 12.2 Filgrastim Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Filgrastim Distributors
- 12.2.3 Filgrastim Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst